InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,463.54
(
0.08%
)
US TECH 100
18,596.40
(
0.22%
)
Dow Jones
40,539.93
(
0.00%
)
Brent Oil
78.59
(
-0.71%
)
Bitcoin
66,657.67
(
-0.25%
)
Post# of 252727
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BTH

Send PM Follow Ignore
Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: jq1234 post# 149697

Sunday, 09/30/2012 11:05:34 PM

Sunday, September 30, 2012 11:05:34 PM

Post# of 252727
Given the way the MARQUEE trial is stratified, sub-groups etc and the secondary endpoints....could it be possible if the overall population failed to meet the necessary endpoint, but the secondary endpoints showed positive endpoints? Can they submit that to the FDA for approval in subtypes, or would you think they would be required to do another Phase 3?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up